COMMUNIQUÉS West-GlobeNewswire

QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
27/06/2024
American Academy of Pediatrics in the United States now recommends IGRA tests like QuantiFERON-TB Gold Plus to screen at-risk children of all ages // New recommendation joins trend of U.S. tuberculosis control [...]
Avadel Pharmaceuticals to Join Russell 3000® Index
27/06/2024
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad- [...]
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
27/06/2024
Company Anticipates Completion of Patient Enrollment in the STRIVE-ON Trial in Late 2024 to Early 2025, with Potential NDA Submission on Track for 1H Calendar 2025 PRINCETON, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- [...]
Elicio Therapeutics Announces Proposed Public Offering
27/06/2024
BOSTON, June 27, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]
Accolade Announces Results for Fiscal First Quarter 2025
27/06/2024
SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the [...]
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
27/06/2024
Eliem to focus on advancing TNT119, an anti-CD19 antibody designed to treat a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia and membranous nephropathy Post-close [...]
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
27/06/2024
ELI-002 7P administered as a monotherapy at the Phase 2 dose shows preliminary encouraging Disease-Free Survival data in pancreatic ductal adenocarcinoma BOSTON, June 27, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, [...]
Journal of Respirology Publishes Clinical Trial Data Demonstrating the Benefits of Noah Medical’s Galaxy System
27/06/2024
FRONTIER Study demonstrates Galaxy System’s use of proprietary TiLT + Technology to successfully navigate peripheral pulmonary nodules, achieving 100% tool-in-lesion confirmation and 89.5-94.7% diagnostic yield SAN [...]
Healthcare Financial Management Association Recognizes Center for Medicare and Medicaid Innovation Director Elizabeth Fowler for Contributions to Healthcare
27/06/2024
LAS VEGAS, June 27, 2024 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) presented its highest achievement award, the Richard L. Clarke Board of Directors Award, to CMS Deputy Administrator [...]
Ezra Launches AI-Fueled, Whole-Body MRI in Seattle in Partnership with Imaging Leader RAYUS Radiology
27/06/2024
Healthcare startup brings first-of-its-kind early cancer detection technology to Pacific Northwest NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Ezra , the healthcare AI startup transforming early cancer detection through [...]
Bioxytran’s Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer’s Patients
27/06/2024
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke [...]
La revue Allergy désignée comme publication ayant le plus grand impact en allergologie et immunologie clinique pour 2024
27/06/2024
ZURICH, Suisse, 27 juin 2024 (GLOBE NEWSWIRE) -- L’European Academy of Allergy and Clinical Immunology (EAACI) est ravie d’annoncer que Allergy , l’une des revues officielles de l’EAACI, a été reconnue comme la revue à [...]
PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€
27/06/2024
Lyon (France), le 27 juin 2024 - 17h45 CEST - PHAXIAM Therapeutics (la « Société »), société biopharmaceutique qui développe des traitements innovants contre les infections bactériennes sévères et résistantes, annonce [...]
Nicox: 2024 Ordinary Shareholder Meeting
27/06/2024
Press Release Nicox: 2024 Ordinary Shareholder Meeting June 27, 2024 – release at 17:30 CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, ALCOX), an international ophthalmology company, informs its [...]
Nicox : Assemblée Générale Ordinaire 2024
27/06/2024
Communiqué de presse Nicox : Assemblée Générale Ordinaire 2024 27 juin 2024 – diffusion à 17h30 Sophia Antipolis, France Nicox SA (Euronext Paris : FR0013018124, ALCOX, éligible PEA-PME), société internationale [...]
CloudMD Securityholders Approve Go-Private Transaction with CPS Capital
27/06/2024
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, is [...]
Dermatology Group of Arkansas Member Earns Nursing Degree
27/06/2024
Savannah Norwood completed her master’s degree while working at Dermatology Group of Arkansas and is now a nurse practitioner at the respected practice serving the entire Little Rock area LITTLE ROCK, Ark., June 27, [...]
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
27/06/2024
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation is based on pre-clinical and epidemiological data showing [...]
LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement
27/06/2024
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has met the closing [...]

Pages